Titration: why the GLP-1 dose goes up gradually

People who start a GLP-1 medication usually notice that treatment doesn’t begin “at full strength.” The first step is lighter, and the amount of medication goes up gradually, in steps, over weeks or months. This process has a name: titration.

In this article, you’ll learn what titration is, why it exists and what can help you get through this phase. We won’t talk about dose numbers: they’re in the label and are set by your doctor, based on your situation.

What titration is

Titration is the process of starting a medication at a lower amount and gradually increasing it, in steps, until you reach the maintenance dose, the one you’ll use from then on.

This isn’t unique to GLP-1s. Many medications are started this way, to give the body time to adjust. For this class, the labels include an escalation schedule, with how long each step lasts and the maintenance dose.

Why start slowly

The main reason is comfort for your stomach and gut. Gastrointestinal effects, such as nausea, diarrhea, vomiting and constipation, are among the most common with these medications.

The U.S. prescribing information for semaglutide for weight management explains that the gradual dose escalation is there to reduce the risk of these gastrointestinal reactions. In other words: starting slowly gives your body a chance to adapt to each step before moving on to the next.

In the STEP 1 trial, which evaluated semaglutide for treating obesity, nausea and diarrhea were the most frequent side effects. According to the authors, they were usually temporary, mild to moderate, and eased over time.

What to expect in this phase

Everyone reacts differently, but some things are common:

• Symptoms tend to show up more at the start. That’s when the body is still adapting.
• Your appetite changes. Fullness comes sooner, and portions naturally shrink.
• Each step takes its time. The full schedule can take weeks or months to reach maintenance.

None of this is a reason to speed up or slow down on your own. The pace of titration follows the label and your doctor’s assessment.

Why not skip steps

It can be tempting to “go faster” to reach the maintenance dose sooner, especially when the scale is slow to move in the first weeks. But titration exists precisely to make treatment more tolerable. Skipping steps on your own can make the discomfort worse and get in the way of your treatment.

The same goes the other way: if side effects are bothering you, what to do is your doctor’s call. Don’t change how you use the medication without guidance. Follow the label and talk with the people following your care.

Habits that help during titration

An expert consensus published in 2023 on managing the gastrointestinal effects of these medications brings together a few simple measures, especially useful early in treatment:

• Eat slowly and chew well.
• Choose smaller portions, more often through the day, if that suits you.
• Stop when you’re satisfied. You don’t need to clean your plate.
• Eat when you’re hungry, without forcing meals.
• Go easy on fried and very greasy foods.
• Avoid carbonated drinks and alcohol, which can add to the discomfort.
• Don’t lie down right after eating.

And don’t forget water: with less food on your plate, hydration deserves attention, especially on days with symptoms.

When to see your doctor

See your doctor if the nausea doesn’t improve, if you’re vomiting often, if you can’t keep fluids down, if you notice signs of dehydration, such as a very dry mouth, little urine or dizziness, or if you have severe belly pain that doesn’t go away.

Log each step

Recording the date of each injection, which step you’re on and your symptoms each day helps you spot patterns: when side effects show up, how long they last, what seems to help. These notes are very useful at your appointment, because they show your doctor how your body is responding to each phase.

Titration is a phase of adjustment. With patience, good mealtime habits and close follow-up, it usually goes much more smoothly.

Sources

• U.S. Food and Drug Administration. Wegovy® (semaglutide): prescribing information. FDA.
• Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine, 2021.
• Gorgojo-Martínez JJ, et al. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. Journal of Clinical Medicine, 2023.